A
ANGIODYNAMICS INC
NASDAQ: ANGO (AngioDynamics, Inc.)
Last update: 2 hours ago8.89
0.31 (3.61%)
| Previous Close | 8.58 |
| Open | 8.52 |
| Volume | 541,524 |
| Avg. Volume (3M) | 588,073 |
| Market Cap | 361,238,048 |
| Price / Earnings (Forward) | 96.15 |
| Price / Sales | 1.23 |
| Price / Book | 1.84 |
| 52 Weeks Range | |
| Earnings Date | 8 Jan 2025 |
| Profit Margin | -83.02% |
| Operating Margin (TTM) | -12.91% |
| Diluted EPS (TTM) | -6.05 |
| Quarterly Revenue Growth (YOY) | -14.20% |
| Total Debt/Equity (MRQ) | 2.76% |
| Current Ratio (MRQ) | 2.25 |
| Operating Cash Flow (TTM) | -20.51 M |
| Levered Free Cash Flow (TTM) | 24.19 M |
| Return on Assets (TTM) | -6.12% |
| Return on Equity (TTM) | -77.85% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Instruments & Supplies (US) | Mixed | Mixed |
| Medical Instruments & Supplies (Global) | Mixed | Mixed | |
| Stock | AngioDynamics, Inc. | Bearish | Bearish |
AIStockmoo Score
0.9
| Analyst Consensus | 3.0 |
| Insider Activity | NA |
| Price Volatility | -5.0 |
| Technical Moving Averages | 1.5 |
| Technical Oscillators | 4.0 |
| Average | 0.88 |
|
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device. |
|
| Sector | Healthcare |
| Industry | Medical Instruments & Supplies |
| Investment Style | Small Value |
| % Held by Insiders | 5.61% |
| % Held by Institutions | 81.31% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Kent Lake Pr Llc | 30 Sep 2024 | 1,000,000 |
| Segall Bryant & Hamill, Llc | 30 Sep 2024 | 911,443 |
| Kent Lake Capital Llc | 30 Jun 2024 | 750,000 |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 14.00 (HC Wainwright & Co., 57.48%) | Buy |
| Median | 13.00 (46.23%) | |
| Low | 12.00 (Canaccord Genuity, 34.98%) | Buy |
| Average | 13.00 (46.23%) | |
| Total | 2 Buy | |
| Avg. Price @ Call | 7.50 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| HC Wainwright & Co. | 10 Dec 2024 | 14.00 (57.48%) | Buy | 8.89 |
| 04 Oct 2024 | 14.00 (57.48%) | Buy | 6.10 | |
| Canaccord Genuity | 04 Oct 2024 | 12.00 (34.98%) | Buy | 6.10 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |